Reversal of refractory septic shock with drotrecogin alpha (activated)

被引：0
|
作者：
A. Vieillard-Baron
V. Caille
C. Charron
G. Belliard
P. Aegerter
B. Page
F. Jardin
机构：
[1] Centre Hospitalier Universitaire Ambroise Paré,Medical Intensive Care Unit, Service de Réanimation Médicale
[2] University Hospital Ambroise Paré,Department of Biostatistics
[3] Assistance Publique Hôpitaux de Paris,undefined
来源：
Intensive Care Medicine | 2009年 / 35卷
关键词：
Sepsis; Septic shock; Circulatory failure; Multiple organ failure; Lactic acidosis; Hemodiafiltration; Drotrecogin alpha;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1204 / 1209
页数：5
相关论文
共 50 条
  • [21] Drotrecogin alfa (activated) did not reduce mortality at 28 or 90 days in patients with septic shock
    Brun-Buisson, Christian
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (04)
  • [22] Acute hemodynamic changes during drotrecogin alen (activated) (DTAA) infusion in septic shock.
    Thomas, JJ
    Octaviani-Agostini, R
    Steingrub, JS
    Tidswell, M
    Higgins, TL
    CRITICAL CARE MEDICINE, 2005, 33 (12) : A9 - A9
  • [23] Variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock: a meta-analysis
    Zhang, Da-Long
    Zhu, Hui-Yun
    Zhang, Shuai
    Wu, Qing-Qing
    Zhang, Wan-Jiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (09): : 12976 - 12985
  • [24] Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock
    Herbert Spapen
    Duc Nam Nguyen
    Joris Troubleyn
    Luc Huyghens
    Johan Schiettecatte
    Critical Care, 14
  • [25] Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock
    Spapen, Herbert
    Nguyen, Duc Nam
    Troubleyn, Joris
    Huyghens, Luc
    Schiettecatte, Johan
    CRITICAL CARE, 2010, 14 (02):
  • [26] REVERSAL OF REFRACTORY HYPOTENSION IN SEPTIC SHOCK BY INHIBITOR OF NITRIC-OXIDE SYNTHASE
    LIN, PJ
    CHANG, CH
    CHANG, JP
    CHEST, 1994, 106 (02) : 626 - 629
  • [27] Use of drotrecogin alfa activated in septic AIDS patients.
    Rowden, AM
    PHARMACOTHERAPY, 2004, 24 (10): : 1429 - 1429
  • [28] An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock
    Lai, P. S.
    Matteau, A.
    Iddriss, A.
    Hawes, C. L.
    Ranieri, V. M.
    Thompson, B. T.
    MINERVA ANESTESIOLOGICA, 2013, 79 (01) : 33 - 43
  • [29] Initiation of drotrecogin alfa (activated) [DTAA] versus placebo infusion acutely improves hemodynamics in patients with septic shock
    Thomas, Joss J.
    Tidswell, Mark
    Shah, Archan
    Octaviani, Raul
    Kozikowski, Krystal
    Nathanson, Brian
    Steingrub, Jay
    CHEST, 2006, 130 (04) : 149S - 150S
  • [30] Refractory septic shock to norepinephrine
    Meresse, Zoe
    Medam, Sophie
    Mathieu, Calypso
    Leone, Marc
    ANESTHESIE & REANIMATION, 2019, 5 (04): : 315 - 321
12345